Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Sex-specific nanomedicine- and biomaterials-based therapies of chronic wounds

Nature Reviews Bioengineering volume 2, pages 447–449 (2024)Cite this article

Subjects

Wound healing mechanisms differ depending on the sex, particularly in chronic wounds. Therefore, sex should be considered in the design of nanomedicine- and biomaterials-based wound healing therapies, both in preclinical and clinical testing.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Nanomedicine and biomaterials design for wound healing should consider sex.

References

  1. Falanga, V. et al. Chronic wounds. Nat. Rev. Dis. Primers 8, 50 (2022).

    Article  Google Scholar 

  2. Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).

    Article  Google Scholar 

  3. Zeeuwen, P. L. J. M. et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 13, R101 (2012).

    Article  Google Scholar 

  4. Kalan, L. R. et al. Strain- and species-level variation in the microbiome of diabetic wounds is associated with clinical outcomes and therapeutic efficacy. Cell Host Microbe 25, 641–655.e645 (2019).

    Article  Google Scholar 

  5. Freedman, B. R. et al. Breakthrough treatments for accelerated wound healing. Sci. Adv. 9, eade7007 (2023).

    Article  Google Scholar 

  6. Hajipour, M. J. et al. Sex as an important factor in nanomedicine. Nat. Commun. 12, 2984 (2021).

    Article  Google Scholar 

  7. Chen, L., Guo, S., Ranzer, M. J. & DiPietro, L. A. Toll-like receptor 4 has an essential role in early skin wound healing. J. Investig. Dermatol. 133, 258–267 (2013).

    Article  Google Scholar 

  8. Mirani, B. et al. Smart dual‐sensor wound dressing for monitoring cutaneous wounds. Adv. Healthc. Mater. 12, 2203233 (2023).

    Article  Google Scholar 

  9. Matoori, S., Veves, A. & Mooney, D. J. Advanced bandages for diabetic wound healing. Sci. Transl. Med. 13, eabe4839 (2021).

    Article  Google Scholar 

  10. Huang, W. et al. The efficacy and safety of acellular matrix therapy for diabetic foot ulcers: a meta-analysis of randomized clinical trials. J. Diabetes Res. 2020, 6245758 (2020).

    Article  Google Scholar 

  11. Zhang, P. et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann. Med. 49, 106–116 (2017).

    Article  Google Scholar 

  12. Gentzkow, G. D. et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care 19, 350–354 (1996).

    Article  Google Scholar 

  13. Hanft, J. R. & Surprenant, M. S. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J. Foot Ankle Surg. 41, 291–299 (2002).

    Article  Google Scholar 

Download references

Acknowledgements

L.G. and M.M. gratefully acknowledge financial support from the US National Institute of Diabetes and Digestive and Kidney Diseases (grant DK131417). I.P. acknowledges support from the US National Institute of Diabetes and Digestive and Kidney Diseases (grant R01DK136241). D.R.N. gratefully acknowledges the support of the Australian Research Council for a Future Fellowship (FT230100220).

Author information

Authors and Affiliations

  1. The Graeme Clark Institute, The University of Melbourne, Melbourne, Victoria, Australia

    Negar Mahmoudi & David R. Nisbet

  2. Department of Biomedical Engineering, Faculty of Engineering and Information Technology, The University of Melbourne, Melbourne, Victoria, Australia

    Negar Mahmoudi & David R. Nisbet

  3. Melbourne Medical School, Faculty of Medicine, Dentistry and Health Science, The University of Melbourne, Melbourne, Victoria, Australia

    David R. Nisbet

  4. Dr Phillip Frost Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA

    Irena Pastar

  5. Warren Alpert Medical School of Brown University, Providence, RI, USA

    Lisa Gould

  6. South Shore Health Center for Wound Healing, Weymouth, MA, USA

    Lisa Gould

  7. Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada

    Simon Matoori

  8. Department of Radiology and Precision Health Program, College of Human Medicine, Michigan State University, East Lansing, MI, USA

    Morteza Mahmoudi

  9. Connors Center for Women’s Health & Gender Biology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USA

    Morteza Mahmoudi

Authors
  1. Negar Mahmoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David R. Nisbet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Irena Pastar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lisa Gould
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Simon Matoori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Morteza Mahmoudi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed equally to this Comment.

Corresponding author

Correspondence to Morteza Mahmoudi.

Ethics declarations

Competing interests

M.M. discloses that he is a co-founder of Academic Parity Movement and Targets’ Tip; he receives royalties/honoraria for his published books, plenary lectures and licensed patents. D.R.N. discloses that he is the co-founder and CEO of NanoStratus Pty. Ltd. He receives honoraria for his editorial responsibilities, plenary lectures and licensed patents. The remaining authors declare no competing interests.

Additional information

Related links

US National Institute of Health: https://orwh.od.nih.gov/sex-gender/orwh-mission-area-sex-gender-in-research/nih-policy-on-sex-as-biological-variable

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahmoudi, N., Nisbet, D.R., Pastar, I. et al. Sex-specific nanomedicine- and biomaterials-based therapies of chronic wounds. Nat Rev Bioeng 2, 447–449 (2024). https://doi.org/10.1038/s44222-024-00191-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44222-024-00191-4

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research